Surgery Partners Company Insiders
SGRY Stock | USD 23.84 0.43 1.84% |
Surgery Partners' insiders are aggressively selling. The analysis of insiders' sentiment of trading Surgery Partners stock suggests that vertually all insiders are panicking at this time. Surgery Partners employs about 10.5 K people. The company is managed by 16 executives with a total tenure of roughly 27 years, averaging almost 1.0 years of service per executive, having 656.25 employees per reported executive.
Wayne DeVeydt Chairman Executive Chairman |
Jennifer Baldock President Senior Vice President General Counsel, Secretary |
Surgery Partners' Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-06-12 | Danielle Burkhalter | Disposed 6000 @ 26.39 | View | ||
2024-05-31 | Bradley R Owens | Disposed 6000 @ 27.65 | View | ||
2024-03-13 | Jason Eric Evans | Disposed 4840 @ 29.71 | View | ||
2024-03-11 | Jason Eric Evans | Disposed 1984 @ 29.44 | View | ||
2024-02-12 | Jason Eric Evans | Disposed 5780 @ 35.08 | View | ||
2024-02-06 | Danielle Burkhalter | Disposed 167 @ 32.24 | View | ||
2024-02-02 | Marissa Brittenham | Disposed 1637 @ 31.89 | View | ||
2023-12-19 | Andrew T Kaplan | Disposed 7826870 @ 33.44 | View |
Monitoring Surgery Partners' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Surgery |
Surgery Partners' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Surgery Partners' future performance. Based on our forecasts, it is anticipated that Surgery will maintain a workforce of slightly above 10500 employees by January 2025.Surgery Partners Management Team Effectiveness
The company has return on total asset (ROA) of 0.039 % which means that it generated a profit of $0.039 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0308 %, meaning that it created $0.0308 on every $100 dollars invested by stockholders. Surgery Partners' management efficiency ratios could be used to measure how well Surgery Partners manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 0.07 in 2024, whereas Return On Tangible Assets are likely to drop (0.01) in 2024. At this time, Surgery Partners' Intangibles To Total Assets are fairly stable compared to the past year. Debt To Assets is likely to rise to 0.59 in 2024, whereas Total Assets are likely to drop slightly above 4.6 B in 2024.Common Stock Shares Outstanding is likely to rise to about 131.9 M in 2024, whereas Net Loss is likely to drop (51.6 M) in 2024.
Surgery Partners Workforce Comparison
Surgery Partners is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 280,631. Surgery Partners holds roughly 10,500 in number of employees claiming about 4% of equities under Health Care industry.
Surgery Partners Profit Margins
The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.31 | 0.236 |
|
| |||||
Operating Profit Margin | 0.15 | 0.1196 |
|
|
Surgery Partners Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgery Partners insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgery Partners' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Surgery Partners insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-09-01 | 1.0 | 2 | 2 | 3,128 | 6,325 |
2024-06-01 | 2.5 | 5 | 2 | 30,850 | 12,000 |
2024-03-01 | 0.4 | 12 | 30 | 151,052 | 53,383 |
2023-12-01 | 0.0769 | 1 | 13 | 100,000 | 33,512,743 |
2023-06-01 | 1.6667 | 5 | 3 | 20,960 | 28,082 |
2023-03-01 | 0.4286 | 15 | 35 | 277,401 | 125,093 |
2022-12-01 | 5.0 | 5 | 1 | 27,581,019 | 4,338 |
2022-06-01 | 0.5556 | 5 | 9 | 20,150 | 129,414 |
2022-03-01 | 0.4706 | 16 | 34 | 178,753 | 194,009 |
2021-09-01 | 0.5 | 1 | 2 | 2,000 | 184.00 |
2021-06-01 | 0.1667 | 2 | 12 | 45,217,850 | 814,279 |
2021-03-01 | 1.069 | 31 | 29 | 404,758 | 94,583 |
2020-12-01 | 0.1111 | 1 | 9 | 4,199 | 16,274 |
2020-03-01 | 2.75 | 11 | 4 | 503,785 | 11,915 |
2019-09-01 | 1.0 | 3 | 3 | 51,000 | 115,423 |
2019-06-01 | 3.0 | 6 | 2 | 647,923 | 9,063 |
2019-03-01 | 1.2778 | 23 | 18 | 1,962,079 | 29,616 |
2018-12-01 | 1.0 | 5 | 5 | 208,169 | 201,991 |
2018-09-01 | 2.0 | 4 | 2 | 31,460 | 19,789 |
2018-06-01 | 0.25 | 1 | 4 | 14,749 | 0.00 |
2018-03-01 | 2.0 | 8 | 4 | 882,077 | 3,621 |
2017-12-01 | 0.25 | 1 | 4 | 67,264 | 2,846 |
2017-03-01 | 2.0 | 10 | 5 | 117,433 | 11,580 |
2016-09-01 | 2.0 | 2 | 1 | 22,024 | 2,500 |
2015-12-01 | 0.3333 | 1 | 3 | 4,015 | 1,477,430 |
2015-09-01 | 0.1667 | 1 | 6 | 4,473 | 0.00 |
Surgery Partners Notable Stakeholders
A Surgery Partners stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Surgery Partners often face trade-offs trying to please all of them. Surgery Partners' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Surgery Partners' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Wayne DeVeydt | Executive Chairman | Profile | |
Bradley Owens | President Group | Profile | |
Harrison Bane | President Group | Profile | |
Jennifer Baldock | Senior Vice President General Counsel, Secretary | Profile | |
Eric Evans | COO, Executive Vice President | Profile | |
Anthony Taparo | President - Atlantic Group | Profile | |
David Doherty | Executive CFO | Profile | |
David CPA | Executive CFO | Profile | |
Spencer Clark | General VP | Profile | |
Danielle Burkhalter | Executive Officer | Profile | |
Jennifer JD | Executive Officer | Profile | |
Roxanne Womack | Senior Officer | Profile | |
Neil Zieselman | Senior Controller | Profile | |
Kristi Jensen | Senior Region | Profile | |
Marissa Brittenham | Executive Officer | Profile | |
Varun Gadhok | Senior Officer | Profile |
About Surgery Partners Management Performance
The success or failure of an entity such as Surgery Partners often depends on how effective the management is. Surgery Partners management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Surgery management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Surgery management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.00 | (0.01) | |
Return On Capital Employed | 0.05 | 0.07 | |
Return On Equity | (0.01) | (0.01) |
Please note, the imprecision that can be found in Surgery Partners' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Surgery Partners. Check Surgery Partners' Beneish M Score to see the likelihood of Surgery Partners' management manipulating its earnings.
Surgery Partners Workforce Analysis
Traditionally, organizations such as Surgery Partners use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Surgery Partners within its industry.Surgery Partners Manpower Efficiency
Return on Surgery Partners Manpower
Revenue Per Employee | 261.3K | |
Revenue Per Executive | 171.5M | |
Net Loss Per Employee | 1.1K | |
Net Loss Per Executive | 743.8K | |
Working Capital Per Employee | 35.4K | |
Working Capital Per Executive | 23.2M |
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.